Clinical Trials Directory

Trials / Conditions / Stage IIIA Fallopian Tube Cancer

Stage IIIA Fallopian Tube Cancer

18 registered clinical trials studyying Stage IIIA Fallopian Tube Cancer.

StatusTrialSponsorPhase
WithdrawnPET Imaging of Ovarian Carcinoma With 18F-FSPG
NCT02872519
Vanderbilt-Ingram Cancer CenterEARLY_Phase 1
WithdrawnSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito
NCT02833506
Roswell Park Cancer InstitutePhase 1
TerminatedIGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, o
NCT03029611
University of WashingtonPhase 2
WithdrawnActivated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian
NCT02470559
Barbara Ann Karmanos Cancer InstitutePhase 1
CompletedMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone
NCT02122185
University of ChicagoPhase 2
WithdrawnVaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or
NCT01982487
Roswell Park Cancer InstitutePhase 1 / Phase 2
CompletedSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri
NCT01536054
Roswell Park Cancer InstitutePhase 1
CompletedVaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri
NCT01606241
Mayo ClinicPhase 1
TerminatedGranisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap
NCT01275664
Gynecologic Oncology GroupN/A
CompletedPsychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
NCT01764802
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedOPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca
NCT00857545
Gynecologic Oncology GroupPhase 2
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedGlutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian
NCT02311907
Alliance for Clinical Trials in OncologyPhase 3
CompletedTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl
NCT01010126
National Cancer Institute (NCI)Phase 2
TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal
NCT00899093
Gynecologic Oncology Group—
CompletedSunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal
NCT00388037
National Cancer Institute (NCI)Phase 2
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian
NCT00262847
National Cancer Institute (NCI)Phase 3
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—